Latest
-
How to invest in the latest developments in hearing technology
Cover Story Traditionally dismissed as a relative backwater, this branch of medicine is about to move into the limelight thanks to ageing populations and major breakthroughs, says Matthew Partridge
Cover Story -
Vanquishing the virus: the race to make vaccines for Covid-19
Cover Story The extraordinarily rapid development of effective treatments against the coronavirus is a triumph of biotechnology, says Dr Mike Tubbs. He reviews the story and explains what it means for investors.
Cover Story -
Vexing vaccine delays hit drug firms
News AstraZeneca and Pfizer are being attacked by the EU over what it claims are delays in delivering the Covid vaccine.
News -
AstraZeneca turns the tables as it acquires US pharmaceutical firm Alexion
News AstraZeneca, the British pharma giant, was almost swallowed up by Pfizer a few years ago. Now it has struck a megadeal of its own. Matthew Partridge reports
News -
The lessons of “Operation Warp Speed” – the race to produce a vaccine
Opinion Governments and companies can learn from the extraordinary global effort to create a vaccine to defeat Covid-19, says Matthew Lynn.
Opinion -
The MoneyWeek Podcast: Barry Norris on why he's shorting vaccine-makers
Podcasts The news of Covid vaccines has delighted many. But not Argonaut Capital's Barry Norris. He tells Merryn why vaccines aren't the panacea people think they are, and how our extended lockdown could have permanently changed our way of life. Plus, he picks one health-focused value stock to buy now.
Podcasts -
Big Pharma deserves its reward for coming up with Covid-19 vaccines
Opinion Calls to restrain drug companies' profits from making Covid-19 vaccines are misplaced and would do more harm than good, says Matthew Lynn
Opinion -
More good news as AstraZeneca finds a third Covid vaccine
News Another week, another Covid-19 vaccine. This one from AstraZeneca and Oxford University is homegrown and ready to roll out fast. Matthew Partridge reports
News -
Moderna’s “stunning” second vaccine
News America’s Moderna has come up with a vaccine even more promising than last week’s offering from Pfizer and BioNTech. Matthew Partridge reports
News
